Organoid Professional Comprehensive Study by Type (Stomach, Intestine, Liver, Pancreas, Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Others), End-users (Pharmaceutical & Biotechnology companies, CROs, Academic & Research Institutes, Others) Players and Region - Global Market Outlook to 2027

Organoid Professional Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Organoid Professional Market Scope
Organoids are 3-dimensional (3D) phone cultures that include some of the key facets of the represented organ. These in vitro lifestyle structures are characterised via the self-organization of multiple, organ-specific telephone kinds into a spatial agency comparable to what is determined in vivo, and are successful of recapitulating some features of the represented organ. Organoids might also be generated from person stem cell-containing tissue samples, single grownup stem cells, or by using the directed differentiation of pluripotent stem cells.3,4 Due to the lively stem phone populace that are current in some organoid mannequin systems, the organoids can be radically expanded. For example, up to 1 x 106 liver organoids can be produced from a single progenitor inside 5 to 6 weeks, giving researchers an exceptionally strong and scalable platform for reading a large vary of subjects.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledBioIVT (United States), Thermo Fisher Scientific (United States), Corning Incorporated (United States), ZenBio (United States), Organovo (United States), InSphero (Switzerland), Kaly-Cell (France), STEMCELL Technologies (Canada), Hµrel Corporation (United States) and CELLINK (United States)
CAGR%


The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Organoid Professional market throughout the predicted period.

BioIVT (United States), Thermo Fisher Scientific (United States), Corning Incorporated (United States), ZenBio (United States), Organovo (United States), InSphero (Switzerland), Kaly-Cell (France), STEMCELL Technologies (Canada), Hµrel Corporation (United States) and CELLINK (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Kirkstall (United States), PRIMACYT Cell Culture Technology (Germany) and Cyprio (United Kingdom).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global Organoid Professional market by Type (Stomach, Intestine, Liver, Pancreas and Others), by Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine and Others) and Region with country level break-up.

On the basis of application, segment is dominating the market in the year 2021

On the basis of geography, the market of Organoid Professional has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2021.

Market Leaders and their expansionary development strategies
In 2020, Cellesce Ltd. entered into a partnership with Manchester BIOGEL to strengthen wholly artificial animal-free three-D (3D) scaffolds that mimic the physiological surroundings in the human physique and allow manufacture, scale-up, and greater reproducibility of patient-derived organoids.



Market Trend
  • Combining Organoid with Organ-On-A-Chip

Market Drivers
  • Increasing Focus on Developing Alternatives for Animal Testing Models
  • Growing Adoption of Personalized Drugs
  • Increasing Demand for Tumor Modelling and Bio banking

Opportunities
  • Growing Focus on Drug Discovery Activities

Restraints
  • Lack of Infrastructure for 3D Cell Culture
  • Limited Growth

Challenges
  • Dearth of Skilled Professionals


Key Target Audience
Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • Stomach
  • Intestine
  • Liver
  • Pancreas
  • Others
By Application
  • Developmental Biology Disease
  • Pathology of Infectious Disease
  • Regenerative Medicine
  • Others
By End-users
  • Pharmaceutical & Biotechnology companies
  • CROs
  • Academic & Research Institutes
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Focus on Developing Alternatives for Animal Testing Models
      • 3.2.2. Growing Adoption of Personalized Drugs
      • 3.2.3. Increasing Demand for Tumor Modelling and Bio banking
    • 3.3. Market Challenges
      • 3.3.1. Dearth of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Combining Organoid with Organ-On-A-Chip
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Organoid Professional, by Type, Application, End-users and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Organoid Professional (Value)
      • 5.2.1. Global Organoid Professional by: Type (Value)
        • 5.2.1.1. Stomach
        • 5.2.1.2. Intestine
        • 5.2.1.3. Liver
        • 5.2.1.4. Pancreas
        • 5.2.1.5. Others
      • 5.2.2. Global Organoid Professional by: Application (Value)
        • 5.2.2.1. Developmental Biology Disease
        • 5.2.2.2. Pathology of Infectious Disease
        • 5.2.2.3. Regenerative Medicine
        • 5.2.2.4. Others
      • 5.2.3. Global Organoid Professional by: End-users (Value)
        • 5.2.3.1. Pharmaceutical & Biotechnology companies
        • 5.2.3.2. CROs
        • 5.2.3.3. Academic & Research Institutes
        • 5.2.3.4. Others
      • 5.2.4. Global Organoid Professional Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Organoid Professional: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BioIVT (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Corning Incorporated (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. ZenBio (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Organovo (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. InSphero (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Kaly-Cell (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. STEMCELL Technologies (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Hµrel Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. CELLINK (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Organoid Professional Sale, by Type, Application, End-users and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Organoid Professional (Value)
      • 7.2.1. Global Organoid Professional by: Type (Value)
        • 7.2.1.1. Stomach
        • 7.2.1.2. Intestine
        • 7.2.1.3. Liver
        • 7.2.1.4. Pancreas
        • 7.2.1.5. Others
      • 7.2.2. Global Organoid Professional by: Application (Value)
        • 7.2.2.1. Developmental Biology Disease
        • 7.2.2.2. Pathology of Infectious Disease
        • 7.2.2.3. Regenerative Medicine
        • 7.2.2.4. Others
      • 7.2.3. Global Organoid Professional by: End-users (Value)
        • 7.2.3.1. Pharmaceutical & Biotechnology companies
        • 7.2.3.2. CROs
        • 7.2.3.3. Academic & Research Institutes
        • 7.2.3.4. Others
      • 7.2.4. Global Organoid Professional Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Organoid Professional: by Type(USD Million)
  • Table 2. Organoid Professional Stomach , by Region USD Million (2016-2021)
  • Table 3. Organoid Professional Intestine , by Region USD Million (2016-2021)
  • Table 4. Organoid Professional Liver , by Region USD Million (2016-2021)
  • Table 5. Organoid Professional Pancreas , by Region USD Million (2016-2021)
  • Table 6. Organoid Professional Others , by Region USD Million (2016-2021)
  • Table 7. Organoid Professional: by Application(USD Million)
  • Table 8. Organoid Professional Developmental Biology Disease , by Region USD Million (2016-2021)
  • Table 9. Organoid Professional Pathology of Infectious Disease , by Region USD Million (2016-2021)
  • Table 10. Organoid Professional Regenerative Medicine , by Region USD Million (2016-2021)
  • Table 11. Organoid Professional Others , by Region USD Million (2016-2021)
  • Table 12. Organoid Professional: by End-users(USD Million)
  • Table 13. Organoid Professional Pharmaceutical & Biotechnology companies , by Region USD Million (2016-2021)
  • Table 14. Organoid Professional CROs , by Region USD Million (2016-2021)
  • Table 15. Organoid Professional Academic & Research Institutes , by Region USD Million (2016-2021)
  • Table 16. Organoid Professional Others , by Region USD Million (2016-2021)
  • Table 17. South America Organoid Professional, by Country USD Million (2016-2021)
  • Table 18. South America Organoid Professional, by Type USD Million (2016-2021)
  • Table 19. South America Organoid Professional, by Application USD Million (2016-2021)
  • Table 20. South America Organoid Professional, by End-users USD Million (2016-2021)
  • Table 21. Brazil Organoid Professional, by Type USD Million (2016-2021)
  • Table 22. Brazil Organoid Professional, by Application USD Million (2016-2021)
  • Table 23. Brazil Organoid Professional, by End-users USD Million (2016-2021)
  • Table 24. Argentina Organoid Professional, by Type USD Million (2016-2021)
  • Table 25. Argentina Organoid Professional, by Application USD Million (2016-2021)
  • Table 26. Argentina Organoid Professional, by End-users USD Million (2016-2021)
  • Table 27. Rest of South America Organoid Professional, by Type USD Million (2016-2021)
  • Table 28. Rest of South America Organoid Professional, by Application USD Million (2016-2021)
  • Table 29. Rest of South America Organoid Professional, by End-users USD Million (2016-2021)
  • Table 30. Asia Pacific Organoid Professional, by Country USD Million (2016-2021)
  • Table 31. Asia Pacific Organoid Professional, by Type USD Million (2016-2021)
  • Table 32. Asia Pacific Organoid Professional, by Application USD Million (2016-2021)
  • Table 33. Asia Pacific Organoid Professional, by End-users USD Million (2016-2021)
  • Table 34. China Organoid Professional, by Type USD Million (2016-2021)
  • Table 35. China Organoid Professional, by Application USD Million (2016-2021)
  • Table 36. China Organoid Professional, by End-users USD Million (2016-2021)
  • Table 37. Japan Organoid Professional, by Type USD Million (2016-2021)
  • Table 38. Japan Organoid Professional, by Application USD Million (2016-2021)
  • Table 39. Japan Organoid Professional, by End-users USD Million (2016-2021)
  • Table 40. India Organoid Professional, by Type USD Million (2016-2021)
  • Table 41. India Organoid Professional, by Application USD Million (2016-2021)
  • Table 42. India Organoid Professional, by End-users USD Million (2016-2021)
  • Table 43. South Korea Organoid Professional, by Type USD Million (2016-2021)
  • Table 44. South Korea Organoid Professional, by Application USD Million (2016-2021)
  • Table 45. South Korea Organoid Professional, by End-users USD Million (2016-2021)
  • Table 46. Taiwan Organoid Professional, by Type USD Million (2016-2021)
  • Table 47. Taiwan Organoid Professional, by Application USD Million (2016-2021)
  • Table 48. Taiwan Organoid Professional, by End-users USD Million (2016-2021)
  • Table 49. Australia Organoid Professional, by Type USD Million (2016-2021)
  • Table 50. Australia Organoid Professional, by Application USD Million (2016-2021)
  • Table 51. Australia Organoid Professional, by End-users USD Million (2016-2021)
  • Table 52. Rest of Asia-Pacific Organoid Professional, by Type USD Million (2016-2021)
  • Table 53. Rest of Asia-Pacific Organoid Professional, by Application USD Million (2016-2021)
  • Table 54. Rest of Asia-Pacific Organoid Professional, by End-users USD Million (2016-2021)
  • Table 55. Europe Organoid Professional, by Country USD Million (2016-2021)
  • Table 56. Europe Organoid Professional, by Type USD Million (2016-2021)
  • Table 57. Europe Organoid Professional, by Application USD Million (2016-2021)
  • Table 58. Europe Organoid Professional, by End-users USD Million (2016-2021)
  • Table 59. Germany Organoid Professional, by Type USD Million (2016-2021)
  • Table 60. Germany Organoid Professional, by Application USD Million (2016-2021)
  • Table 61. Germany Organoid Professional, by End-users USD Million (2016-2021)
  • Table 62. France Organoid Professional, by Type USD Million (2016-2021)
  • Table 63. France Organoid Professional, by Application USD Million (2016-2021)
  • Table 64. France Organoid Professional, by End-users USD Million (2016-2021)
  • Table 65. Italy Organoid Professional, by Type USD Million (2016-2021)
  • Table 66. Italy Organoid Professional, by Application USD Million (2016-2021)
  • Table 67. Italy Organoid Professional, by End-users USD Million (2016-2021)
  • Table 68. United Kingdom Organoid Professional, by Type USD Million (2016-2021)
  • Table 69. United Kingdom Organoid Professional, by Application USD Million (2016-2021)
  • Table 70. United Kingdom Organoid Professional, by End-users USD Million (2016-2021)
  • Table 71. Netherlands Organoid Professional, by Type USD Million (2016-2021)
  • Table 72. Netherlands Organoid Professional, by Application USD Million (2016-2021)
  • Table 73. Netherlands Organoid Professional, by End-users USD Million (2016-2021)
  • Table 74. Rest of Europe Organoid Professional, by Type USD Million (2016-2021)
  • Table 75. Rest of Europe Organoid Professional, by Application USD Million (2016-2021)
  • Table 76. Rest of Europe Organoid Professional, by End-users USD Million (2016-2021)
  • Table 77. MEA Organoid Professional, by Country USD Million (2016-2021)
  • Table 78. MEA Organoid Professional, by Type USD Million (2016-2021)
  • Table 79. MEA Organoid Professional, by Application USD Million (2016-2021)
  • Table 80. MEA Organoid Professional, by End-users USD Million (2016-2021)
  • Table 81. Middle East Organoid Professional, by Type USD Million (2016-2021)
  • Table 82. Middle East Organoid Professional, by Application USD Million (2016-2021)
  • Table 83. Middle East Organoid Professional, by End-users USD Million (2016-2021)
  • Table 84. Africa Organoid Professional, by Type USD Million (2016-2021)
  • Table 85. Africa Organoid Professional, by Application USD Million (2016-2021)
  • Table 86. Africa Organoid Professional, by End-users USD Million (2016-2021)
  • Table 87. North America Organoid Professional, by Country USD Million (2016-2021)
  • Table 88. North America Organoid Professional, by Type USD Million (2016-2021)
  • Table 89. North America Organoid Professional, by Application USD Million (2016-2021)
  • Table 90. North America Organoid Professional, by End-users USD Million (2016-2021)
  • Table 91. United States Organoid Professional, by Type USD Million (2016-2021)
  • Table 92. United States Organoid Professional, by Application USD Million (2016-2021)
  • Table 93. United States Organoid Professional, by End-users USD Million (2016-2021)
  • Table 94. Canada Organoid Professional, by Type USD Million (2016-2021)
  • Table 95. Canada Organoid Professional, by Application USD Million (2016-2021)
  • Table 96. Canada Organoid Professional, by End-users USD Million (2016-2021)
  • Table 97. Mexico Organoid Professional, by Type USD Million (2016-2021)
  • Table 98. Mexico Organoid Professional, by Application USD Million (2016-2021)
  • Table 99. Mexico Organoid Professional, by End-users USD Million (2016-2021)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Organoid Professional: by Type(USD Million)
  • Table 111. Organoid Professional Stomach , by Region USD Million (2022-2027)
  • Table 112. Organoid Professional Intestine , by Region USD Million (2022-2027)
  • Table 113. Organoid Professional Liver , by Region USD Million (2022-2027)
  • Table 114. Organoid Professional Pancreas , by Region USD Million (2022-2027)
  • Table 115. Organoid Professional Others , by Region USD Million (2022-2027)
  • Table 116. Organoid Professional: by Application(USD Million)
  • Table 117. Organoid Professional Developmental Biology Disease , by Region USD Million (2022-2027)
  • Table 118. Organoid Professional Pathology of Infectious Disease , by Region USD Million (2022-2027)
  • Table 119. Organoid Professional Regenerative Medicine , by Region USD Million (2022-2027)
  • Table 120. Organoid Professional Others , by Region USD Million (2022-2027)
  • Table 121. Organoid Professional: by End-users(USD Million)
  • Table 122. Organoid Professional Pharmaceutical & Biotechnology companies , by Region USD Million (2022-2027)
  • Table 123. Organoid Professional CROs , by Region USD Million (2022-2027)
  • Table 124. Organoid Professional Academic & Research Institutes , by Region USD Million (2022-2027)
  • Table 125. Organoid Professional Others , by Region USD Million (2022-2027)
  • Table 126. South America Organoid Professional, by Country USD Million (2022-2027)
  • Table 127. South America Organoid Professional, by Type USD Million (2022-2027)
  • Table 128. South America Organoid Professional, by Application USD Million (2022-2027)
  • Table 129. South America Organoid Professional, by End-users USD Million (2022-2027)
  • Table 130. Brazil Organoid Professional, by Type USD Million (2022-2027)
  • Table 131. Brazil Organoid Professional, by Application USD Million (2022-2027)
  • Table 132. Brazil Organoid Professional, by End-users USD Million (2022-2027)
  • Table 133. Argentina Organoid Professional, by Type USD Million (2022-2027)
  • Table 134. Argentina Organoid Professional, by Application USD Million (2022-2027)
  • Table 135. Argentina Organoid Professional, by End-users USD Million (2022-2027)
  • Table 136. Rest of South America Organoid Professional, by Type USD Million (2022-2027)
  • Table 137. Rest of South America Organoid Professional, by Application USD Million (2022-2027)
  • Table 138. Rest of South America Organoid Professional, by End-users USD Million (2022-2027)
  • Table 139. Asia Pacific Organoid Professional, by Country USD Million (2022-2027)
  • Table 140. Asia Pacific Organoid Professional, by Type USD Million (2022-2027)
  • Table 141. Asia Pacific Organoid Professional, by Application USD Million (2022-2027)
  • Table 142. Asia Pacific Organoid Professional, by End-users USD Million (2022-2027)
  • Table 143. China Organoid Professional, by Type USD Million (2022-2027)
  • Table 144. China Organoid Professional, by Application USD Million (2022-2027)
  • Table 145. China Organoid Professional, by End-users USD Million (2022-2027)
  • Table 146. Japan Organoid Professional, by Type USD Million (2022-2027)
  • Table 147. Japan Organoid Professional, by Application USD Million (2022-2027)
  • Table 148. Japan Organoid Professional, by End-users USD Million (2022-2027)
  • Table 149. India Organoid Professional, by Type USD Million (2022-2027)
  • Table 150. India Organoid Professional, by Application USD Million (2022-2027)
  • Table 151. India Organoid Professional, by End-users USD Million (2022-2027)
  • Table 152. South Korea Organoid Professional, by Type USD Million (2022-2027)
  • Table 153. South Korea Organoid Professional, by Application USD Million (2022-2027)
  • Table 154. South Korea Organoid Professional, by End-users USD Million (2022-2027)
  • Table 155. Taiwan Organoid Professional, by Type USD Million (2022-2027)
  • Table 156. Taiwan Organoid Professional, by Application USD Million (2022-2027)
  • Table 157. Taiwan Organoid Professional, by End-users USD Million (2022-2027)
  • Table 158. Australia Organoid Professional, by Type USD Million (2022-2027)
  • Table 159. Australia Organoid Professional, by Application USD Million (2022-2027)
  • Table 160. Australia Organoid Professional, by End-users USD Million (2022-2027)
  • Table 161. Rest of Asia-Pacific Organoid Professional, by Type USD Million (2022-2027)
  • Table 162. Rest of Asia-Pacific Organoid Professional, by Application USD Million (2022-2027)
  • Table 163. Rest of Asia-Pacific Organoid Professional, by End-users USD Million (2022-2027)
  • Table 164. Europe Organoid Professional, by Country USD Million (2022-2027)
  • Table 165. Europe Organoid Professional, by Type USD Million (2022-2027)
  • Table 166. Europe Organoid Professional, by Application USD Million (2022-2027)
  • Table 167. Europe Organoid Professional, by End-users USD Million (2022-2027)
  • Table 168. Germany Organoid Professional, by Type USD Million (2022-2027)
  • Table 169. Germany Organoid Professional, by Application USD Million (2022-2027)
  • Table 170. Germany Organoid Professional, by End-users USD Million (2022-2027)
  • Table 171. France Organoid Professional, by Type USD Million (2022-2027)
  • Table 172. France Organoid Professional, by Application USD Million (2022-2027)
  • Table 173. France Organoid Professional, by End-users USD Million (2022-2027)
  • Table 174. Italy Organoid Professional, by Type USD Million (2022-2027)
  • Table 175. Italy Organoid Professional, by Application USD Million (2022-2027)
  • Table 176. Italy Organoid Professional, by End-users USD Million (2022-2027)
  • Table 177. United Kingdom Organoid Professional, by Type USD Million (2022-2027)
  • Table 178. United Kingdom Organoid Professional, by Application USD Million (2022-2027)
  • Table 179. United Kingdom Organoid Professional, by End-users USD Million (2022-2027)
  • Table 180. Netherlands Organoid Professional, by Type USD Million (2022-2027)
  • Table 181. Netherlands Organoid Professional, by Application USD Million (2022-2027)
  • Table 182. Netherlands Organoid Professional, by End-users USD Million (2022-2027)
  • Table 183. Rest of Europe Organoid Professional, by Type USD Million (2022-2027)
  • Table 184. Rest of Europe Organoid Professional, by Application USD Million (2022-2027)
  • Table 185. Rest of Europe Organoid Professional, by End-users USD Million (2022-2027)
  • Table 186. MEA Organoid Professional, by Country USD Million (2022-2027)
  • Table 187. MEA Organoid Professional, by Type USD Million (2022-2027)
  • Table 188. MEA Organoid Professional, by Application USD Million (2022-2027)
  • Table 189. MEA Organoid Professional, by End-users USD Million (2022-2027)
  • Table 190. Middle East Organoid Professional, by Type USD Million (2022-2027)
  • Table 191. Middle East Organoid Professional, by Application USD Million (2022-2027)
  • Table 192. Middle East Organoid Professional, by End-users USD Million (2022-2027)
  • Table 193. Africa Organoid Professional, by Type USD Million (2022-2027)
  • Table 194. Africa Organoid Professional, by Application USD Million (2022-2027)
  • Table 195. Africa Organoid Professional, by End-users USD Million (2022-2027)
  • Table 196. North America Organoid Professional, by Country USD Million (2022-2027)
  • Table 197. North America Organoid Professional, by Type USD Million (2022-2027)
  • Table 198. North America Organoid Professional, by Application USD Million (2022-2027)
  • Table 199. North America Organoid Professional, by End-users USD Million (2022-2027)
  • Table 200. United States Organoid Professional, by Type USD Million (2022-2027)
  • Table 201. United States Organoid Professional, by Application USD Million (2022-2027)
  • Table 202. United States Organoid Professional, by End-users USD Million (2022-2027)
  • Table 203. Canada Organoid Professional, by Type USD Million (2022-2027)
  • Table 204. Canada Organoid Professional, by Application USD Million (2022-2027)
  • Table 205. Canada Organoid Professional, by End-users USD Million (2022-2027)
  • Table 206. Mexico Organoid Professional, by Type USD Million (2022-2027)
  • Table 207. Mexico Organoid Professional, by Application USD Million (2022-2027)
  • Table 208. Mexico Organoid Professional, by End-users USD Million (2022-2027)
  • Table 209. Research Programs/Design for This Report
  • Table 210. Key Data Information from Secondary Sources
  • Table 211. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Organoid Professional: by Type USD Million (2016-2021)
  • Figure 5. Global Organoid Professional: by Application USD Million (2016-2021)
  • Figure 6. Global Organoid Professional: by End-users USD Million (2016-2021)
  • Figure 7. South America Organoid Professional Share (%), by Country
  • Figure 8. Asia Pacific Organoid Professional Share (%), by Country
  • Figure 9. Europe Organoid Professional Share (%), by Country
  • Figure 10. MEA Organoid Professional Share (%), by Country
  • Figure 11. North America Organoid Professional Share (%), by Country
  • Figure 12. Global Organoid Professional share by Players 2021 (%)
  • Figure 13. Global Organoid Professional share by Players (Top 3) 2021(%)
  • Figure 14. Global Organoid Professional share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. BioIVT (United States) Revenue, Net Income and Gross profit
  • Figure 17. BioIVT (United States) Revenue: by Geography 2021
  • Figure 18. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 19. Thermo Fisher Scientific (United States) Revenue: by Geography 2021
  • Figure 20. Corning Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 21. Corning Incorporated (United States) Revenue: by Geography 2021
  • Figure 22. ZenBio (United States) Revenue, Net Income and Gross profit
  • Figure 23. ZenBio (United States) Revenue: by Geography 2021
  • Figure 24. Organovo (United States) Revenue, Net Income and Gross profit
  • Figure 25. Organovo (United States) Revenue: by Geography 2021
  • Figure 26. InSphero (Switzerland) Revenue, Net Income and Gross profit
  • Figure 27. InSphero (Switzerland) Revenue: by Geography 2021
  • Figure 28. Kaly-Cell (France) Revenue, Net Income and Gross profit
  • Figure 29. Kaly-Cell (France) Revenue: by Geography 2021
  • Figure 30. STEMCELL Technologies (Canada) Revenue, Net Income and Gross profit
  • Figure 31. STEMCELL Technologies (Canada) Revenue: by Geography 2021
  • Figure 32. Hµrel Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Hµrel Corporation (United States) Revenue: by Geography 2021
  • Figure 34. CELLINK (United States) Revenue, Net Income and Gross profit
  • Figure 35. CELLINK (United States) Revenue: by Geography 2021
  • Figure 36. Global Organoid Professional: by Type USD Million (2022-2027)
  • Figure 37. Global Organoid Professional: by Application USD Million (2022-2027)
  • Figure 38. Global Organoid Professional: by End-users USD Million (2022-2027)
  • Figure 39. South America Organoid Professional Share (%), by Country
  • Figure 40. Asia Pacific Organoid Professional Share (%), by Country
  • Figure 41. Europe Organoid Professional Share (%), by Country
  • Figure 42. MEA Organoid Professional Share (%), by Country
  • Figure 43. North America Organoid Professional Share (%), by Country
List of companies from research coverage that are profiled in the study
  • BioIVT (United States)
  • Thermo Fisher Scientific (United States)
  • Corning Incorporated (United States)
  • ZenBio (United States)
  • Organovo (United States)
  • InSphero (Switzerland)
  • Kaly-Cell (France)
  • STEMCELL Technologies (Canada)
  • Hµrel Corporation (United States)
  • CELLINK (United States)
Additional players considered in the study are as follows:
Kirkstall (United States) , PRIMACYT Cell Culture Technology (Germany) , Cyprio (United Kingdom)
Select User Access Type

Key Highlights of Report


May 2022 212 Pages 74 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Organoid Professional study can be customized to meet your requirements. The market size breakdown by type [Stomach, Intestine, Liver, Pancreas and Others], by end use application [Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine and Others].
The Organoid Professional Market is gaining popularity and expected to see strong valuation by 2027.

Know More About Global Organoid Professional Market Report?